As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Biotech-stock investing has one tough test for success - and it's about to get easier ...

Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...

Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

has accepted for review the resubmitted New Drug Application (NDA) for topical ocular reproxalap, a first-in-class investigational new drug candidate, for the treatment of the signs and symptoms of ...

announced that the U.S. Food and Drug Administration or FDA has accepted for review the resubmitted New Drug Application NDA for topical ocular reproxalap, a first-in-class investigational new drug ...

Nanoform Finland Plc. November 18, 2024. 08:10 a.m. Finnish time / 07:10 a.m. Swedish time. Nanoform Q3 2024 report: Record number of new projects signed. A ...

Prince Harry has been living in the US with wife Meghan Markle and their two children since the couple stepped back as senior ...